(DSTL) Distillate US Fundamental - Overview
Etf: Equity, Large Cap, Value
Dividends
| Dividend Yield | 1.36% |
| Yield on Cost 5y | 2.20% |
| Yield CAGR 5y | 13.21% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 11.8% |
| Relative Tail Risk | -2.01% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.40 |
| Alpha | -3.25 |
| Character TTM | |
|---|---|
| Beta | 0.730 |
| Beta Downside | 0.734 |
| Drawdowns 3y | |
|---|---|
| Max DD | 16.92% |
| CAGR/Max DD | 0.83 |
Description: DSTL Distillate US Fundamental January 15, 2026
The Distillate US Fundamental Stability & Value ETF (NYSE ARCA:DSTL) is an actively managed fund that allocates at least 80 % of its net assets-and any investment-purpose borrowings-to U.S. equities selected for perceived valuation attractiveness, cash-flow resilience, and strong balance-sheet metrics.
As of the most recent filing (Q4 2025), DSTL reports an expense ratio of 0.55 %, a dividend yield near 2.1 %, and a median market-cap of roughly $12 B, placing it squarely in the large-value segment. Its top holdings are concentrated in consumer staples, health care, and industrials, sectors historically less sensitive to cyclical downturns.
Key macro drivers for DSTL’s performance include the Federal Reserve’s policy stance-higher rates tend to pressure growth-oriented stocks while benefitting value-oriented, cash-flow-rich companies-and the U.S. consumer confidence index, which underpins earnings stability in the fund’s core sectors.
For a deeper dive into DSTL’s risk-adjusted returns and how its factor tilt compares to peers, you may find ValueRay’s analytics platform a useful next step.
What is the price of DSTL shares?
Over the past week, the price has changed by +2.67%, over one month by +2.72%, over three months by +9.71% and over the past year by +9.87%.
Is DSTL a buy, sell or hold?
What are the forecasts/targets for the DSTL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 69.7 | 13.3% |
DSTL Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.90b USD (1.90b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 1.90b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.90b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.60% (E(1.90b)/V(1.90b) * Re(8.60%) + (debt-free company))
Discount Rate = 8.60% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)